According to Noxopharm latest financial reports the cash on hand of NOX is $2.04M, an decrease of -78.53% to 2022. At the end of 2022 company had $9.48M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $2.04M | -78.53% |
2022 | $9.48M | -47.71% |
2021 | $18.13M | 277.39% |
2020 | $4.80M | 144.03% |
2019 | $1.97M | - |